2016
DOI: 10.1016/j.jbspin.2015.10.005
|View full text |Cite
|
Sign up to set email alerts
|

Sicca symptoms are associated with similar fatigue, anxiety, depression, and quality-of-life impairments in patients with and without primary Sjögren's syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
37
0
3

Year Published

2016
2016
2019
2019

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 65 publications
(43 citation statements)
references
References 32 publications
3
37
0
3
Order By: Relevance
“…Three studies12,24,26 made comparisons between the PCS in pSS patients and controls. Patients with pSS had significantly lower values (MD, −12.34; 95% CI: −18.42, −6.26; P <0.0001), with heterogeneity among studies ( P =0.0008) and I 2 =86%.…”
Section: Resultsmentioning
confidence: 99%
“…Three studies12,24,26 made comparisons between the PCS in pSS patients and controls. Patients with pSS had significantly lower values (MD, −12.34; 95% CI: −18.42, −6.26; P <0.0001), with heterogeneity among studies ( P =0.0008) and I 2 =86%.…”
Section: Resultsmentioning
confidence: 99%
“…A study showed that 47% of the working age pSS patients received disability compensation, because they were considered to be (partially) unfit for work 47. The same study also reports that significantly more patients with the following demographic/disease characteristics receive disability compensation: male patients, patients with a high educational level, an increasing number of systemic manifestations and/or the use of artificial saliva and/or HCQ 40, 41, 47.…”
Section: Clinical Presentationmentioning
confidence: 98%
“…Additionally, sicca syndrome also includes hoarseness, non-productive cough, skin dryness and, in woman, dyspareunia 38, 39. Patients with pSS experience a significantly decreased quality of life compared to subjects with sicca syndrome without autoimmune features as measured by the SF-36 depression scale 40, 41.…”
Section: Clinical Presentationmentioning
confidence: 99%
“…The chief treatment goal in chronic and usually non‐life‐threatening conditions such as primary SS is to improve the patient's perceived health‐related quality of life (HRQOL). HRQOL is profoundly impaired in primary SS . Therefore, the principal factors governing HRQOL impairment must be identified so that they can be specifically targeted by therapeutic interventions, to improve the patient's everyday experience.…”
Section: Introductionmentioning
confidence: 99%